• Oklo Inc. recently secured US Nuclear Regulatory Commission approval for its Aurora reactor design, reported a first-quarter 2026 net loss of US$33.07 million, and filed for an at-the-market follow-on equity offering of up to US$1.00 billion in common stock.
• At the same time, Oklo deepened its work with Idaho National Laboratory to apply AI tools to advanced reactor and fuel-system design, aligning its capital raise, regulatory progress, and technology partnerships around moving its Aurora and Pluto systems toward commercial use.
• We’ll now examine how NRC approval for Aurora and the new US$1.00 billion at-the-market program affect Oklo’s investment narrative.

Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Oklo Investment Narrative Recap

To own Oklo, you have to believe compact fast reactors, integrated fuel, and isotope assets can turn today’s losses into future contracted power and services. The near term catalyst is moving Aurora and Pluto from design into actual build and deployment, while the biggest risk is extended pre revenue losses and dilution if timelines slip. The new US$1.00 billion at the market program reinforces that funding risk is front and center, but does not materially change the core catalyst.

The most relevant recent announcement here is the NRC’s approval of Oklo’s Principal Design Criteria for Aurora, which tightens the link between regulatory progress and capital raises. Together with the new US$1.00 billion program and the previously completed US$1.50 billion offering, Oklo is clearly positioning its balance sheet around that licensing track, reinforcing that execution on first reactors and fuel facilities is the hinge for future value creation.

But while the potential is appealing, investors should also be aware that continued losses, share issuance and fuel supply uncertainty could...

Oklo's narrative projects $51.8 million in revenue and $7.5 million in earnings by 2029. This requires moving from no revenue today to $51.8 million by 2029, and an earnings improvement of about $84.1 million from -$76.6 million today.

Uncover how Oklo's forecasts yield a $112.13 fair value, a 72% upside to its current price.

Exploring Other Perspectives

Some of the lowest analyst estimates paint a far more cautious picture, with revenue of only about US$13.1 million and earnings of roughly US$1.9 million by 2029, reminding you that reasonable people can read the same milestones, including a US$1.00 billion equity program, and still reach very different conclusions about Oklo’s path from funding to profitable reactors.

Explore 48 other fair value estimates on Oklo - why the stock might be worth as much as 72% more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Oklo research is our analysis highlighting 1 key reward and 5 important warning signs that could impact your investment decision.
• Our free Oklo research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Oklo's overall financial health at a glance.

Curious About Other Options?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 27 best rare earth metal stocks of the very few that mine this essential strategic resource.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.